United Guardian (UG) FCF Payout Ratio Growth (1y) (2011 - 2026)
Powered by 
Analysis
United Guardian (UG) FCF Payout Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.97 Bn | 622.21 Bn | 17.26 Bn | -59.92% |
| 2 | AbbVie | 441.24 Bn | 434.67 Bn | 12.70 Bn | 65.46% |
| 3 | Merck | 364.65 Bn | 357.51 Bn | 12.21 Bn | -41.69% |
| 4 | Novartis Ag | 266.30 Bn | 258.61 Bn | 11.24 Bn | 30.28% |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -44.83% |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | - |
| 8 | Incyte | 25.27 Bn | 20.73 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | - |
| 10 | United Guardian | 32.67 Mn | 23.07 Mn | 1.55 Mn | -97.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.49% |
| Mar 31, 2026 | -61.74% |
| Sep 30, 2025 | -14.05% |
| Mar 31, 2025 | 173.51% |
| Sep 30, 2024 | 220.24% |
| Dec 31, 2022 | 27.53% |
| Jun 30, 2022 | -99.97% |
| Dec 31, 2021 | -27.51% |
| Jun 30, 2021 | 33.93% |
| Dec 31, 2020 | -16.04% |
| Jun 30, 2020 | -55.94% |
| Dec 31, 2019 | 22.84% |
| Dec 31, 2018 | -59.51% |
| Dec 31, 2017 | 90.99% |
| Dec 31, 2016 | 46.65% |
| Dec 31, 2015 | 129.72% |
| Dec 31, 2014 | -13.53% |
| Dec 31, 2013 | 113.06% |
| Dec 31, 2012 | -365.17% |
| Dec 31, 2011 | 106.10% |